Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid for Omeprazole-Induced Hypochlorhydria
NCT04199624Phase 1Completed
- Sponsor
- Indiana University
- Start
- Oct 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ascorbic acid in hypochlorhydria, sponsored by Indiana University. Primary endpoint: Change in gastric pH and duration of gastric pH status at Day 5. Started Oct 2021; status: completed.
02
Drugs
ascorbic acid
03
Conditions
hypochlorhydria
Beyond the preview
Go deeper on NCT04199624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04199624.